These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11704752)

  • 21. Efficacy and safety of 1 % terbinafine film-forming solution in Chinese patients with tinea pedis: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study.
    Li RY; Wang AP; Xu JH; Xi LY; Fu MH; Zhu M; Xu ML; Li XQ; Lai W; Liu WD; Lu XY; Gong ZQ
    Clin Drug Investig; 2014 Mar; 34(3):223-30. PubMed ID: 24477462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of ajoene in the treatment of tinea pedis: a double-blind and comparative study with terbinafine.
    Ledezma E; Marcano K; Jorquera A; De Sousa L ; Padilla M; Pulgar M; Apitz-Castro R
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):829-32. PubMed ID: 11050588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Seven days of intermittent terbinafine 250 mg treatment in Tinea pedis].
    Hamaguchi T; Takiuchi I
    Nihon Ishinkin Gakkai Zasshi; 2002; 43(2):79-83. PubMed ID: 12040364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.
    Bergstresser PR; Elewski B; Hanifin J; Lesher J; Savin R; Shupack J; Stiller M; Tschen E; Zaias N; Birnbaum JE
    J Am Acad Dermatol; 1993 Apr; 28(4):648-51. PubMed ID: 8463471
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study.
    Brown M; Evans C; Muddle A; Turner R; Lim S; Reed J; Traynor M
    Am J Clin Dermatol; 2013 Oct; 14(5):413-9. PubMed ID: 23740211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar-type tinea pedis.
    Hay RJ; McGregor JM; Wuite J; Ryatt KS; Ziegler C; Clayton YM
    Br J Dermatol; 1995 Apr; 132(4):604-8. PubMed ID: 7748753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis.
    Shi TW; Zhang JA; Zhang XW; Yu HX; Tang YB; Yu JB
    Mycoses; 2014 Sep; 57(9):560-4. PubMed ID: 24697872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of chronic moccasin-type tinea pedis with terbinafine: a double-blind, placebo-controlled trial.
    Savin RC; Zaias N
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):804-7. PubMed ID: 2229528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study.
    De Keyser P; De Backer M; Massart DL; Westelinck KJ
    Br J Dermatol; 1994 Apr; 130 Suppl 43():22-5. PubMed ID: 8186137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis.
    Savin RC
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):807-9. PubMed ID: 2229529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.
    Schäfer-Korting M; Schoellmann C; Korting HC
    Skin Pharmacol Physiol; 2008; 21(4):203-10. PubMed ID: 18509254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: results of placebo-controlled multicenter trials.
    Savin R; Atton AV; Bergstresser PR; Elewski B; Jones HE; Levine N; Leyden J; Monroe A; Pandya A; Shupack J
    J Am Acad Dermatol; 1994 Apr; 30(4):663-7. PubMed ID: 8157801
    [No Abstract]   [Full Text] [Related]  

  • 33. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
    Savin R; De Villez RL; Elewski B; Hong S; Jones T; Lowe N; Lucky A; Reyes B; Stewart D; Willis I
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus.
    Tausch I; Decroix J; Gwiezdzinski Z; Urbanowski S; Baran E; Ziarkiewicz M; Levy G; Del Palacio A
    Int J Dermatol; 1998 Feb; 37(2):140-2. PubMed ID: 9542675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful 2-week treatment with terbinafine (Lamisil) for moccasin tinea pedis and tinea manuum.
    White JE; Perkins PJ; Evans EG
    Br J Dermatol; 1991 Sep; 125(3):260-2. PubMed ID: 1911319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel, single-dose, topical treatment of tinea pedis using terbinafine: results of a dose-finding clinical trial.
    de Chauvin MF; Viguié-Vallanet C; Kienzler JL; Larnier C
    Mycoses; 2008 Jan; 51(1):1-6. PubMed ID: 18076588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Terbinafine versus miconazole in patients with tinea pedis].
    Vermeer BJ; Staats CC; van Houwelingen JC
    Ned Tijdschr Geneeskd; 1996 Aug; 140(31):1605-8. PubMed ID: 8768815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-duration oral terbinafine for the treatment of tinea pedis in HIV-positive patients.
    Smith S; Houpt K; Rich P; LaMarca A; Weinberg JM; Alferez TS; Atillasoy E; Opper C
    Cutis; 2001 Jul; 68(1 Suppl):30-9. PubMed ID: 11499332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis.
    Ablon G; Rosen T; Spedale J
    Int J Dermatol; 1996 Aug; 35(8):591-3. PubMed ID: 8854165
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment outcome and relapse with short-term oral terbinafine (250 mg/day) in tinea pedis.
    Takiuchi I; Morishita N; Hamaguchi T; Ninomiya J; Higuchi R
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):285-9. PubMed ID: 16282972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.